Skip to main content

Table 6 Association between sub-clinical cardiotoxicity (EF changes ≥ 10%) and the changes in electrocardiographic (ECG) parameters six months after the completion of anthracycline chemotherapy

From: Electrocardiographic and biochemical analysis of anthracycline induced cardiotoxicity in breast cancer patients from Southern Sri Lanka

 

QTc interval ≤ 440 ms

QTc interval > 440 ms

EF difference (EF3-EF0) < 10%

100 (75.8%)

32 (24.2%)

EF difference (EF3-EF0) ≥ 10%

34 (53.1%)

30 (46.9%)

  1. n = 196, p-value = 0.002**
  2. EF; Ejection fraction, p values *< 0.05, **< 0.01, ***< 0.001 considered as significant